Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06463340 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of SGR-3515 In Participants With Advanced Solid Tumors.

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 13 to 14v12
  2. Study sites: 10 to 13v11
  3. Study sites: 9 to 10v10
  4. Study sites: 8 to 9v9
  5. Study sites: 7 to 8v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 6 to 7
    • Study description revised
    v7
  2. Study sites: 5 to 6v6
  3. Study sites: 4 to 5v5
  4. Study sites: 3 to 4v4
  5. Study sites: 1 to 3v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 24, 2024 to Jun 18, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to learn about the effects of a new study drug, called SGR-3515 that may be a treatment for advanced solid tumors.
Trial Details
NCT Number NCT06463340
Lead Sponsor Schrödinger, Inc.
Conditions
(from sponsor)		 Advanced Solid Tumor
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov